CSIMarket
 




Us-china Biomedical Technology, Inc.  (CLDS)
Other Ticker:  
 
    Sector  Services    Industry Advertising
   Industry Advertising
   Sector  Services
 



CLDS Price to Sales Ratio (Feb 28 2018) (Nov 30 2017) (Aug 31 2017) (May 31 2017)
Sales Trailing 12 Months IV. Quarter III. Quarter II. Quarter I. Quarter
Price to Sales (TTM) Ratio current            -            -            -            -            -
Revenue TTM Y / Y Change - % - % - % - % - %
Revenue Y / Y Change - % - % - % - % - %
Stock performance to date 8855.81 % -81.3 % 59 %

Price to sales ratio Comment
Us-china Biomedical Technology, Inc. recorded loss in trailing twelve months.

Within Services sector only one company has lower Price to sales ratio

What is Price to Sales Ratio?
Sales growth by Us-china Biomedical Technology, Inc. Segment

Price to sales ratio Company Ranking
Within: No.
Industry #1
Sector #2
S&P 500 #4






Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com